Brief: Pila Pharma Applies For Orphan Drug Designation In The USA

Pila Pharma AB

22/04/2022 08:11

April 22 (Reuters) - Pila Pharma AB  PILA.ST :
    * PILA PHARMA BUILDS PIPELINE - APPLIES FOR ORPHAN DRUG
DESIGNATION IN THE USA
    * SUBMITTED A REQUEST FOR AN ORPHAN DRUG DESIGNATION TO U.S.
FOOD
AND DRUG ADMINISTRATION (FDA) FOR COMPANY'S DEVELOPMENT
CANDIDATE XEN-D0501
    * AIM IS TO DEVELOP A NOVEL TREATMENT OF A RARE DISEASE
ASSOCIATED
WITH PAIN DUE TO NEUROGENIC INFLAMMATION

Source text for Eikon:  ID:nBQN1WKQ1H 
Further company coverage:  PILA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))